Warning: Last items in stock!
Availability date: 2013-06-07
|Target Animal:||Dogs and Cats|
|Related Condition:||For use in dogs and cats in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa|
|Pet Prescription Required?:||Yes (For UK Orders)|
|Product Name:||50mg Baytril Flavour Tablet - per Tablet|
|Pack Size:||Sold Individually|
Baytril may only be supplied with a valid veterinary prescription issued by your vet. You should only purchase Baytril if you have or are in the process of arranging such a prescription. See information bar for further details.
Baytril Flavour Tablets 50 mg are light brown to brown slightly marbled round scored flavoured tablets containing 50 mg Enrofloxacin for oral administration to dogs.
Baytril is a synthetic broad spectrum antimicrobial substance belonging to the fluoroquinolone group of antibiotics. It is bactericidal in action and effective against many gram positive and gram negative bacteria and mycoplasmas. The product is for use in dogs and cats in the treatment of bacterial infections of the alimentary respiratory and urogenital tracts skin secondary wound infections and otitis externa where clinical experience supported where possible by sensitivity testing of the causal organism indicates enrofloxacin as the drug of choice.
Dosage and administration
Dogs and cats The dose rate of enrofloxacin is 5 mg/kg given orally once daily or as a divided dose twice daily for 3 to 10 days with or without food. Treatment may be initiated with Baytril 5% Solution for Injection or Baytril 2.5% Solution for Injection and maintained with the tablets. The daily dose is achieved as follows: Cats and small dogs: Baytril 15 mg 1 tablet per 3 kg bodyweight Medium dogs: Baytril 50 mg 1 tablet per 10 kg bodyweight Large dogs: Baytril 150 mg 1 tablet per 30 kg bodyweight Use during pregnancy and lactation The product may be used safely in pregnant and lactating animals.
Contra-indications warnings etc
Baytril flavour tablets should not be used for prophylaxis. Not for use in dogs less than 1 year of age or in exceptionally large breeds of dog with a longer growth period under 18 months of age as articular cartilage may be affected during the period of rapid growth. Not recommended for use in cats less than 8 weeks of age. Do not exceed the recommended dose. In accidental overdose vomiting diarrhoea and CNS/behavioural changes may occur. There is no antidote and treatment should be symptomatic. In cats retinotoxic effects including blindness can occur when the recommended dose is exceeded. In target animal studies cats have been shown to suffer ocular damage after receiving doses of more than 15 mg/kg once daily for 21 consecutive days. Doses of 30 mg/kg given once daily for 21 consecutive days have been shown to cause irreversible ocular damage. At 50 mg/kg given once daily for 21 consecutive days blindness can occur.
Do not store above 25c. Store in a dry place. Unused product or waste material should be disposed of in accordance with current practice for pharmaceutical waste under national waste disposal regulations. Further information Enrofloxacin is a synthetic broad spectrum antimicrobial substance belonging to the fluoroquinolone group of antibiotics. Enrofloxacin is bactericidal in action with activity against Gram positive and Gram negative bacteria and mycoplasmas. The mechanism of action of the quinolones is unique among antimicrobials they act primarily to inhibit bacterial DNA gyrase an enzyme responsible for controlling the supercoiling of bacterial DNA during replication. Resealing of the double standard helix is inhibited resulting in irreversible degradation of the chromosomal DNA. The fluoroquinolones also possess activity against bacteria in the stationary phase by an alteration of the permeability of the outer membrane phospholipid cell wall. The pharmacokinetics of enrofloxacin are such that oral and parenteral administration lead to similar serum levels. Enrofloxacin possesses a high distribution volume. Tissue levels 2-3 times higher than that found in the serum have been demonstrated in laboratory animals and target species. Organs in which high levels can be expected are the lungs liver kidney skin bone and lymphatic system. Enrofloxacin also distributes into the C.S.F. the aqueous humour and the foetus in pregnant animals.
Baytril is a POM-V (Pet Prescription Required)